Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online October 20, 2005
Stem Cells Vol. 24 No. 3 March 2006, pp. 506 -513
doi:10.1634/stemcells.2005-0282; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2005-0282v1
24/3/506    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haraguchi, N.
Right arrow Articles by Mori, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haraguchi, N.
Right arrow Articles by Mori, M.
CANCER STEM CELLS

Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System

Naotsugu Haraguchia, Tohru Utsunomiyaa, Hiroshi Inouea, Fumiaki Tanakaa, Koshi Mimoria, Graham F. Barnardb, Masaki Moria

a Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan;
b Division of Gastroenterology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA

Key Words. Liver cancer • MDR1 • BCRP1 • Microarray • Chemosensitivity assay • Invasion assay

Correspondence: Masaki Mori, M.D., Ph.D., Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Tsurumihara 4546, Beppu 874-0838, Japan. Telephone: +81-977-27-1650; Fax: +81-977-27-1651; e-mail: mmori{at}tsurumi.beppu.kyushu-u.ac.jp

Received June 24, 2005; accepted for publication October 13, 2005.
A subset of stem cells, termed "side population" (SP) cells, has been identified and characterized in several mammalian tissues and cell lines. However, SP cells have never been identified or isolated from gastrointestinal cancers. We used flow cytometry and the DNA-binding dye Hoechst 33342 to isolate SP cells from various human gastrointestinal system cancer cell lines. Fifteen of sixteen cancer cell lines from the gastrointestinal system contained 0.3%–2.2% SP cells. Next, we used an oligonucleotide microarray to analyze differentially expressed genes between SP and non-SP cells of hepatoma HuH7. The expression of GATA6, which is associated with embryonic development and hepatocytic differentiation, was significantly upregulated in HuH7 SP cells. The expression of ABCG2, ABCB1, and CEACAM6, which are associated with chemoresistance, was also significantly increased in SP cells. In addition, some epithelial markers and mesenchymal markers were overexpressed in SP cells. Reverse transcription-polymerase chain reaction and immunocytochemical staining validated these results and suggested a multilineage potential for HuH7 SP cells. In hepatoma HuH7 and colorectal SW480 cell lines, SP cells showed evidence for self-renewal, generating both SP and non-SP cells. Finally, chemoresistance to anticancer agents, including doxorubicin, 5-fluorouracil, and gemcitabine, were compared between HuH7 SP and non-SP cells using an ATP bioluminescence assay. The HuH7 SP cells expressed a higher resistance to doxorubicin, 5-fluorouracil, and gemcitabine compared with non-SP cells. These findings demonstrate that cancers of the gastrointestinal system do contain SP cells that show some characteristics of so-called stem cells.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
C. Hu, H. Li, J. Li, Z. Zhu, S. Yin, X. Hao, M. Yao, S. Zheng, and J. Gu
Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling
Carcinogenesis, December 1, 2008; 29(12): 2289 - 2297.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Chiba, S. Miyagi, A. Saraya, R. Aoki, A. Seki, Y. Morita, Y. Yonemitsu, O. Yokosuka, H. Taniguchi, H. Nakauchi, et al.
The Polycomb Gene Product BMI1 Contributes to the Maintenance of Tumor-Initiating Side Population Cells in Hepatocellular Carcinoma
Cancer Res., October 1, 2008; 68(19): 7742 - 7749.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Tilly and B. R. Rueda
Stem Cell Contribution to Ovarian Development, Function, and Disease
Endocrinology, September 1, 2008; 149(9): 4307 - 4311.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. P. Szotek, H. L. Chang, K. Brennand, A. Fujino, R. Pieretti-Vanmarcke, C. Lo Celso, D. Dombkowski, F. Preffer, K. S. Cohen, J. Teixeira, et al.
Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics
PNAS, August 26, 2008; 105(34): 12469 - 12473.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Moserle, S. Indraccolo, M. Ghisi, C. Frasson, E. Fortunato, S. Canevari, S. Miotti, V. Tosello, R. Zamarchi, A. Corradin, et al.
The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-{alpha} Antitumor Effects
Cancer Res., July 15, 2008; 68(14): 5658 - 5668.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
B. Das, R. Tsuchida, D. Malkin, G. Koren, S. Baruchel, and H. Yeger
Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction
Stem Cells, July 1, 2008; 26(7): 1818 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Zhang, R. Komaki, L. Wang, B. Fang, and J. Y. Chang
Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus
Clin. Cancer Res., May 1, 2008; 14(9): 2813 - 2823.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
U. D. Lichtenauer, I. Shapiro, K. Geiger, M. Quinkler, M. Fassnacht, R. Nitschke, K.-D. Ruckauer, and F. Beuschlein
Side Population Does Not Define Stem Cell-Like Cancer Cells in the Adrenocortical Carcinoma Cell Line NCI h295R
Endocrinology, March 1, 2008; 149(3): 1314 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. Ieta, F. Tanaka, N. Haraguchi, Y. Kita, H. Sakashita, K. Mimori, T. Matsumoto, H. Inoue, H. Kuwano, and M. Mori
Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer
Ann. Surg. Oncol., February 1, 2008; 15(2): 638 - 648.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. P. Hill and R. Perris
"Destemming" Cancer Stem Cells
J Natl Cancer Inst, October 3, 2007; 99(19): 1435 - 1440.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Zen, T. Fujii, S. Yoshikawa, H. Takamura, T. Tani, T. Ohta, and Y. Nakanuma
Histological and Culture Studies with Respect to ABCG2 Expression Support the Existence of a Cancer Cell Hierarchy in Human Hepatocellular Carcinoma
Am. J. Pathol., May 1, 2007; 170(5): 1750 - 1762.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
P. P. Szotek, H. L. Chang, L. Zhang, F. Preffer, D. Dombkowski, P. K. Donahoe, and J. Teixeira
Adult Mouse Myometrial Label-Retaining Cells Divide in Response to Gonadotropin Stimulation
Stem Cells, May 1, 2007; 25(5): 1317 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, L.-P. Guo, L.-Z. Chen, Y.-X. Zeng, and S. H. Lu
Identification of Cancer Stem Cell-Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell Line
Cancer Res., April 15, 2007; 67(8): 3716 - 3724.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. Liu, M. R. Baer, M. J. Bowman, P. Pera, X. Zheng, J. Morgan, R. A. Pandey, and A. R. Oseroff
The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2
Clin. Cancer Res., April 15, 2007; 13(8): 2463 - 2470.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
K. Ishikawa, A. Sasaki, N. Haraguchi, Y. Yoshikawa, and M. Mori
A Case of an {alpha}-Fetoprotein-Producing Intrahepatic Cholangiocarcinoma Suggests Probable Cancer Stem Cell Origin
Oncologist, March 1, 2007; 12(3): 320 - 324.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. A. Kruger, C. D. Kaplan, Y. Luo, H. Zhou, D. Markowitz, R. Xiang, and R. A. Reisfeld
Characterization of stem cell-like cancer cells in immune-competent mice
Blood, December 1, 2006; 108(12): 3906 - 3912.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Morita, H. Ema, S. Yamazaki, and H. Nakauchi
Non-side-population hematopoietic stem cells in mouse bone marrow
Blood, October 15, 2006; 108(8): 2850 - 2856.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.